News | February 10, 2014

Congresswomen Highlights Breast Cancer Detection Bill During Visit to Mammography Vendor

Kuster's Breast Density and Mammography Report Act to promote breast cancer detection, prevention

Breast Density and Mammography Reporting Act Kuster Women's Health
February 10, 2014 — Congresswoman Annie Kuster (NH-02) met Jan. 21 with executives from Gamma Medica to discuss the Breast Density and Mammography Reporting Act. Kuster recently cosponsored the bill in an effort to promote better breast cancer detection and prevention, and to help provide women with the tools to make informed health decisions.
 
“Thousands of women in New Hampshire and across the country are being diagnosed with breast cancer each year. It’s absolutely essential they have every tool available to battle this terrible disease,” Kuster said. “That’s what the Breast Density and Mammography Reporting Act is all about. It will help to make sure women, especially those at greater risk for breast cancer, can detect it early and return to good health.”
 
First introduced by Congresswoman Rosa DeLauro, the bill ensures that relative breast density is included in the information provided to women and health care providers following a mammogram. Studies have shown that women with dense breast tissue are at least four times more likely to develop breast cancer, and they are also more likely to have an inaccurate mammogram reading.
 
Gamma Medica develops, markets and services molecular breast imaging systems to help radiologists detect early stage cancers. The company utilizes molecular breast imaging, a secondary diagnostic tool that enables and improves assessments, especially for women with dense breast tissue.
 
In 2013, an estimated 1,180 Granite State women were projected to be newly diagnosed with breast cancer, according to the New Hampshire Breast Cancer Coalition. An estimated 170 were projected to die of the disease.
 
Earlier this year, Kuster called on the U.S. Department of Health and Human Services (HHS) to cover certain medications that help prevent breast cancer under the Affordable Care Act. HHS issued a ruling that women who are at a higher risk for breast cancer will have access to certain categories of preventative drugs without any out-of-pocket costs.
 
For more information: www.gammamedica.com

Related Content

Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Why guidelines aren't just for patients

Image courtesy of Eizo

Feature | Women's Health | October 04, 2017 | By Stamatia Destounis, M.D., FACR
Over the years, significant progress has been made educating women, men and families about breast cancer — the pink...
Hologic’s new Brevera breast biopsy system allows real-time tissue sample collection and verification on one system

Hologic’s new Brevera breast biopsy system allows real-time tissue sample collection and verification on one system.

Feature | Breast Imaging | October 03, 2017 | By Jeff Zagoudis
When it comes to breast imaging, mammography has long been the gold standard among breast cancer detection technologies...
Overlay Init